THERANOSTICS HEALTH, INC.

Profile

Company Names

THERANOSTICS HEALTH, INC.

Addresses

15010 BROSCHART ROAD, SECOND FLOOR, ROCKVILLE, MD 20850

Phone Numbers

301 251 4443

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$7,208,750.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2015-08-24 
$225,000.00 
$225,000.00 
$0.00 
Equity 
10
2015-01-08 
$1,490,000.00 
$1,490,000.00 
$0.00 
Debt 
9
2014-08-24 
$225,000.00 
$225,000.00 
$0.00 
Equity 
8
2014-08-20 
$855,000.00 
$855,000.00 
$0.00 
Equity 
7
2014-06-12 
$150,000.00 
$150,000.00 
$0.00 
Debt 
6
2014-03-21 
$200,000.00 
$750,000.00 
$550,000.00 
Equity 
5
2013-07-12 
$40,000.00 
$40,000.00 
$0.00 
Debt 
4
2012-07-09 
$1,910,000.00 
$1,910,000.00 
$0.00 
Debt 
3
2011-05-16 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
2
2011-03-22 
$530,000.00 
$530,000.00 
$0.00 
Equity 
1
2010-11-04 
$583,750.00 
$583,750.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSEPH 
BAILES, MD 
DIRECTOR
JAMES 
COOPER, MD 
EXECUTIVE OFFICER, DIRECTOR
MITCHELL 
 
CYBULSKI 
DIRECTOR
MITCHELL 
CYBULSKI 
DIRECTOR
ERIC 
EASTMAN, PHD 
DIRECTOR
LUIS 
GUTIERREZ, JR 
EXECUTIVE OFFICER, DIRECTOR
GLENN 
HOKE, PHD 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
KING 
DIRECTOR
KEVIN 
QUINN 
DIRECTOR
BARRY 
STRAUCH, MD 
DIRECTOR
MICHAEL 
DENDY 
YOUNG 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-06-12 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-24 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-01-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-01-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-21 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-07-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-07-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-07-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-07-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-03-22 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-03-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-03-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-11-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
PICKWICK CAPITAL PARTNERS, LLC
JOHN DIERKES